530125 — Samrat Pharmachem Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹1.29bn
- IN₹1.48bn
- IN₹3.11bn
- 55
- 20
- 41
- 28
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 21.6 | 57.8 | 73.4 | 236 | 225 |
Depreciation | |||||
Non-Cash Items | 9.8 | 9.59 | 12.1 | 5.92 | 10.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.8 | -85 | -42.1 | -73.1 | -336 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 23.7 | -13.3 | 48.3 | 175 | -94.4 |
Capital Expenditures | -2.94 | -18.4 | -27.3 | -12.8 | -13.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 24.7 | -0.792 | -1.95 | 2.13 | -16.5 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 21.8 | -19.2 | -29.2 | -10.6 | -30.1 |
Financing Cash Flow Items | -10.6 | -8.74 | -12.7 | -6.75 | -12.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -39.2 | 20 | -18.9 | -19.5 | 96 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.3 | -12.5 | 0.212 | 145 | -28.4 |